Advanced Search Results For "SAMe-TT2R2"

Publication Type: Academic Journal

Source(s): BMC Cardiovascular Disorders, Vol 23, Iss 1, Pp 1-11 (2023)

Abstract: Abstract Objectives This study aimed to investigate the efficacy and safety outcomes of patients with atrial fibrillation (AF) compared between those taking warfarin and non-vitamin K antagonist oral anticoagulants (NOACs) based on SAMe-TT2R2 score. Me...

Publication Type: Academic Journal

Source(s): Journal of Arrhythmia, Vol 38, Iss 3, Pp 380-385 (2022)

Abstract: Abstract Background There were several limitations to the original HAS‐BLED (oHAS‐BLED) score in patients with atrial fibrillation (AF). This trial studied the revised HAS‐BLED (rHAS‐BLED) score for predicting bleeding events in anticoagulated AF patie...

Publication Type: Academic Journal

Source(s): Patologìâ, Vol 19, Iss 1, Pp 12-17 (2022)

Abstract: The aim. To investigate the influence of clinical and genetic factors on the stability of warfarin’s anticoagulant effect in patients with atrial fibrillation (AF) during the year. Materials and methods. The study involved 60 patients with AF, age 7...

Publication Type: Academic Journal

Source(s): International Journal of Arrhythmia, Vol 22, Iss 1, Pp 1-11 (2021)

Abstract: Abstract Background In many low- to middle-income countries in Asia, patients with NVAF usually received warfarin for thromboembolic prevention due to cost-effectiveness. The SAMe-TT2R2 score has been proposed to predict TTR in NVAF patients. However, ...

Publication Type: Academic Journal

Source(s): Hellenic Journal of Cardiology, Vol 62, Iss 5, Pp 386-388 (2021)

Publication Type: Academic Journal

Source(s): Hellenic Journal of Cardiology, Vol 62, Iss 2, Pp 152-157 (2021)

Abstract: Aim: The SAMe-TT2R2 score helps identify patients with atrial fibrillation (AF) likely to have poor anticoagulation control during anticoagulation with vitamin K antagonists (VKA) and those with scores >2 might be better managed with a target-specific ...

Publication Type: Academic Journal

Source(s): Journal of Arrhythmia, Vol 35, Iss 5, Pp 711-715 (2019)

Abstract: Abstract Background Oral anticoagulant drugs are proven to prevent thromboembolism in patients with atrial fibrillation (AF). To date, HAS‐BLED score is used to assess bleeding risk. This study was conducted to compare simplified HAS‐BLED (sHAS‐BLED) w...

Publication Type: Academic Journal

Source(s): Атеротромбоз, Vol 0, Iss 1, Pp 50-58 (2016)

Abstract: A trial fibrillation is the most common cardiac source of systemic emboli and car-a significant reduction or even blockage of dioembolic stroke. Anticoagulants are recommended for preventing stroke in patients with non-valvular atrial fibrillation. War...

Publication Type: Academic Journal

Source(s): Journal of Clinical Medicine, Vol 8, Iss 6, p 882 (2019)

Abstract: Background: Warfarin requires regular monitoring with the time in therapeutic range (TTR), a common indicator of control and TTR > 70% is indicative of efficient anticoagulation. The SAMe-TT2R2 (sex, age, medical history, treatment, tobacco use, race) ...

Publication Type: Academic Journal

Source(s): The Annals of pharmacotherapy [Ann Pharmacother] 2023 Apr 26, pp. 10600280231166643. Date of Electronic Publication: 2023 Apr 26.

Abstract: Background: The SAMe-TT 2 R 2 score identifies patients on vitamin K antagonists (VKAs) who are more likely to have poor time in therapeutic range (TTR); however, the association between SAMe-TT 2 R 2 and clinical outcomes remains controversial.Objecti...